These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


353 related items for PubMed ID: 29429890

  • 1. Response evaluation of giant-cell tumor of bone treated by denosumab: Histogram and texture analysis of CT images.
    Yi J, Lee YH, Kim SK, Kim SH, Song HT, Shin KH, Suh JS.
    J Orthop Sci; 2018 May; 23(3):570-577. PubMed ID: 29429890
    [Abstract] [Full Text] [Related]

  • 2. Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
    Rekhi B, Verma V, Gulia A, Jambhekar NA, Desai S, Juvekar SL, Bajpai J, Puri A.
    Pathol Oncol Res; 2017 Jan; 23(1):157-164. PubMed ID: 27722984
    [Abstract] [Full Text] [Related]

  • 3. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab].
    Gong LH, Liu WF, Ding Y, Zhang W, Yang YK, Yu F, Wong GQ, Huang XY, Niu XH.
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun 08; 47(6):449-454. PubMed ID: 29886590
    [Abstract] [Full Text] [Related]

  • 4. Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses.
    Kato I, Furuya M, Matsuo K, Kawabata Y, Tanaka R, Ohashi K.
    Histopathology; 2018 May 08; 72(6):914-922. PubMed ID: 29206281
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
    Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME, Razak AR, Griffin AM, Ferguson PC, Wunder JS.
    Eur J Cancer; 2016 May 08; 59():1-12. PubMed ID: 26990281
    [Abstract] [Full Text] [Related]

  • 6. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.
    Roitman PD, Jauk F, Farfalli GL, Albergo JI, Aponte-Tinao LA.
    Hum Pathol; 2017 May 08; 63():89-97. PubMed ID: 28235628
    [Abstract] [Full Text] [Related]

  • 7. Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial.
    Ueda T, Morioka H, Nishida Y, Kakunaga S, Tsuchiya H, Matsumoto Y, Asami Y, Inoue T, Yoneda T.
    Ann Oncol; 2015 Oct 08; 26(10):2149-54. PubMed ID: 26205395
    [Abstract] [Full Text] [Related]

  • 8. Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.
    Girolami I, Mancini I, Simoni A, Baldi GG, Simi L, Campanacci D, Beltrami G, Scoccianti G, D'Arienzo A, Capanna R, Franchi A.
    J Clin Pathol; 2016 Mar 08; 69(3):240-7. PubMed ID: 26338802
    [Abstract] [Full Text] [Related]

  • 9. Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
    Palmerini E, Chawla NS, Ferrari S, Sudan M, Picci P, Marchesi E, Leopardi MP, Syed I, Sankhala KK, Parthasarathy P, Mendanha WE, Pierini M, Paioli A, Chawla SP.
    Eur J Cancer; 2017 May 08; 76():118-124. PubMed ID: 28324746
    [Abstract] [Full Text] [Related]

  • 10. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone].
    Sørensen AL, Hansen RL, Jørgensen PH.
    Ugeskr Laeger; 2016 Sep 05; 178(36):. PubMed ID: 27593237
    [Abstract] [Full Text] [Related]

  • 11. Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab.
    Palmerini E, Seeger LL, Gambarotti M, Righi A, Reichardt P, Bukata S, Blay JY, Dai T, Jandial D, Picci P.
    BMC Cancer; 2021 Jan 22; 21(1):89. PubMed ID: 33482769
    [Abstract] [Full Text] [Related]

  • 12. Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone?
    Hindiskere S, Errani C, Doddarangappa S, Ramaswamy V, Rai M, Chinder PS.
    Clin Orthop Relat Res; 2020 Nov 22; 478(11):2522-2533. PubMed ID: 32401001
    [Abstract] [Full Text] [Related]

  • 13. Giant cell tumor of the bone: aggressive case initially treated with denosumab and intralesional surgery.
    von Borstel D, A Taguibao R, A Strle N, E Burns J.
    Skeletal Radiol; 2017 Apr 22; 46(4):571-578. PubMed ID: 28188337
    [Abstract] [Full Text] [Related]

  • 14. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy.
    Yonezawa N, Murakami H, Kato S, Takeuchi A, Tsuchiya H.
    Eur Spine J; 2017 May 22; 26(Suppl 1):236-242. PubMed ID: 28396950
    [Abstract] [Full Text] [Related]

  • 15. Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone.
    Engellau J, Seeger L, Grimer R, Henshaw R, Gelderblom H, Choy E, Chawla S, Reichardt P, O'Neal M, Feng A, Jacobs I, Roberts ZJ, Braun A, Bach BA.
    World J Surg Oncol; 2018 Sep 19; 16(1):191. PubMed ID: 30231890
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis and monitoring denosumab therapy of giant cell tumors of bone: radiologic-pathologic correlation.
    Lejoly M, Van Den Berghe T, Creytens D, Huysse W, Lapeire L, Sys G, Verstraete K.
    Skeletal Radiol; 2024 Feb 19; 53(2):353-364. PubMed ID: 37515643
    [Abstract] [Full Text] [Related]

  • 17. Radiomics on radiography predicts giant cell tumor histologic response to denosumab.
    Chang YC, Stoyanova R, Danilova S, Pretell-Mazzini JA, Kerr DA, Wilky BA, Subhawong T.
    Skeletal Radiol; 2021 Sep 19; 50(9):1881-1887. PubMed ID: 33733693
    [Abstract] [Full Text] [Related]

  • 18. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
    Müller DA, Beltrami G, Scoccianti G, Campanacci DA, Franchi A, Capanna R.
    World J Surg Oncol; 2016 Nov 04; 14(1):281. PubMed ID: 27809843
    [Abstract] [Full Text] [Related]

  • 19. Denosumab treatment for giant-cell tumor of bone: a systematic review of the literature.
    Luengo-Alonso G, Mellado-Romero M, Shemesh S, Ramos-Pascua L, Pretell-Mazzini J.
    Arch Orthop Trauma Surg; 2019 Oct 04; 139(10):1339-1349. PubMed ID: 30877429
    [Abstract] [Full Text] [Related]

  • 20. Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab.
    Mukaihara K, Suehara Y, Kohsaka S, Akaike K, Tanabe Y, Kubota D, Ishii M, Fujimura T, Kazuno S, Okubo T, Takagi T, Yao T, Kaneko K, Saito T.
    PLoS One; 2016 Oct 04; 11(2):e0148401. PubMed ID: 26863138
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.